CTLA-4 PD-1 TIM-3 CD80 CD86 PD-L1 PD-L2 Galectin-9 MHC LAG3 KIR BTLA HVEM ? B7-H3 ? B7-H4 ? VISTA TIGIT CD155 GITR GITRL 4-1BB 4-1BBL CD40L CD40 OX40 OX40L ICOS ICOSLG SIRPα CD47 LIGHT HVEM CD27 CD70 CD28 CD80 CD86 TCR MHC

Services

Custom Immune Checkpoint Protein Development

With decades of combined experience, highly skilled scientists at Creative Biolabs are ready to get started on your projects. A comprehensive collection of protein production and analysis services for recombinant affinity-tagged or native proteins is available at Creative Biolabs. In addition, we also offer customizable immune checkpoint protein development packages, including stable cell line development and immune checkpoint protein labeling services to meet downstream demands.

Custom Immune Checkpoint Protein Development
Learn More
Immune Checkpoint Antibody Development
Learn More

Immune Checkpoint Antibody Development

Equipped with world-leading technology platforms and professional scientific staff, Creative Biolabs is always dedicated to assisting our clients with the most satisfactory immune checkpoint antibody development services. Our custom services include polyclonal, monoclonal, recombinant antibody development, antibody characterization, engineering, optimization, production, and manufacturing to serve every unique need of our clients in immune checkpoint antibody development projects.

Immune Checkpoint Targeted Peptide Development

Targeted peptides, with various advantages, have great potential in immune checkpoint drug development. As a leader in immune checkpoint drug development, Creative Biolabs is your best partner. Our specialized and dedicated team is available to support our global clients with custom immune checkpoint-targeted peptides development services based on our unparalleled technology platform.

Immune Checkpoint Targeted Peptide Development
Learn More
Immune Checkpoint Targeted Small Molecule Drug Development
Learn More

Immune Checkpoint Targeted Small Molecule Drug Development

With ample experience in drug development and immune checkpoint research, Creative Biolabs is devoted to tailoring the best-fit proposal to screen and identify the desired small molecule candidates with expected functions for our global customers. Our comprehensive small molecule drug development strategies include structure-based drug design, NMR fragment-based drug discovery, organic synthesis, and high-throughput screening.

Biomarker Development for Immune Checkpoint Inhibitor (ICI)

The development of predictive biomarkers is efficient for better treatment outcomes and fewer immune-related adverse events (irAEs). As a pioneer and undisputed global leader, Creative Biolabs is professional in developing advanced biomarkers for immune checkpoint inhibitor (ICI), including but not limited to genetic biomarker development, high-throughput analysis-based biomarker development, and translational biomarker assays.

Biomarker Development for Immune Checkpoint Inhibitor (ICI)
Learn More
Immune Checkpoint Assays
Learn More

Immune Checkpoint Assays

To meet the growing demands for validation of immune checkpoint drug candidates, Creative Biolabs has combined a range of cell-based assays with our state-of-the-art technology and in-depth knowledge to provide a series of immune checkpoint assays with high specificity and sensitivity. We can also work with our customers to design the personalized immune checkpoint assays to fulfill all specific requirements.

Preclinical Research for Immune Checkpoint Drugs

Creative Biolabs has extensive experience in offering optimized preclinical research services for successful immune checkpoint drug discovery. Especially, we provide novel in vivo model development to ensure more reliable drug validation for immune checkpoint drug candidates. Also, we adjust our strategies to meet every specific requirement of global customers.

Preclinical Research for Immune Checkpoint Drugs
Learn More

Subscribe Our Newsletters
to Get Updates about Immune Checkpoint Therapy